{"@type":"Dataset","go_id":["https://identifiers.org/GO:0008152","https://identifiers.org/GO:0006915","https://identifiers.org/GO:0006096"],"go_kw":["metabolism","apoptotic cell death","glycolysis"],"integmet_study":"MTBLS858","mesh_chemical_id":["https://identifiers.org/mesh:D001645","https://identifiers.org/mesh:D008687","https://identifiers.org/mesh:D003847","https://identifiers.org/mesh:D000255"],"mesh_chemical_pubtator_kw":["biguanide","metformin","2-DG","ATP"],"mesh_disease_id":["https://identifiers.org/mesh:D005910","https://identifiers.org/mesh:D009369","https://identifiers.org/mesh:D009447"],"mesh_disease_pubtator_kw":["glioma","malignancies","Neuroblastoma","neuroblastoma","cancer"],"source_id":"https://identifiers.org/metabolights:MTBLS858","study_findings":"2-DG and metformin combination enhances radiosensitivity by disrupting metabolism and inducing G2/M arrest.","study_observation":"Radiosensitising effects of glycolysis and mitochondrial inhibitors on cancer cells.","study_summary":"Radiosensitisation of neuroblastoma and glioma cells studied.","study_title_original":"Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells"}